{"status": "Succeeded", "recognitionResults": [{"page": 1, "clockwiseOrientation": 0.07, "width": 1708, "height": 2287, "unit": "pixel", "lines": [{"boundingBox": [255, 201, 1195, 204, 1194, 242, 254, 239], "text": "7. Significant Bone efficacy (BMD increase) 12 and 24 months", "words": [{"boundingBox": [258, 201, 296, 201, 298, 238, 259, 237], "text": "7."}, {"boundingBox": [306, 201, 461, 202, 462, 240, 308, 238], "text": "Significant"}, {"boundingBox": [468, 202, 550, 202, 552, 241, 469, 240], "text": "Bone"}, {"boundingBox": [557, 203, 671, 203, 672, 241, 559, 241], "text": "efficacy"}, {"boundingBox": [678, 203, 762, 204, 764, 241, 680, 241], "text": "(BMD"}, {"boundingBox": [770, 204, 914, 204, 916, 241, 771, 241], "text": "increase)"}, {"boundingBox": [922, 204, 958, 204, 960, 241, 924, 241], "text": "12"}, {"boundingBox": [965, 204, 1023, 204, 1025, 241, 967, 241], "text": "and"}, {"boundingBox": [1030, 205, 1069, 205, 1071, 240, 1032, 241], "text": "24"}, {"boundingBox": [1076, 205, 1192, 205, 1194, 239, 1078, 240], "text": "months"}]}, {"boundingBox": [256, 238, 1435, 239, 1434, 278, 255, 277], "text": "8. Continuous sequential and continuous combined regimens for individualized", "words": [{"boundingBox": [256, 239, 298, 240, 299, 275, 257, 275], "text": "8."}, {"boundingBox": [305, 240, 477, 241, 479, 277, 306, 275], "text": "Continuous"}, {"boundingBox": [484, 241, 638, 242, 640, 278, 486, 277], "text": "sequential"}, {"boundingBox": [645, 242, 704, 242, 705, 278, 647, 278], "text": "and"}, {"boundingBox": [711, 242, 874, 242, 875, 279, 712, 278], "text": "continuous"}, {"boundingBox": [881, 242, 1025, 242, 1027, 278, 882, 279], "text": "combined"}, {"boundingBox": [1032, 242, 1175, 241, 1176, 278, 1034, 278], "text": "regimens"}, {"boundingBox": [1182, 241, 1221, 241, 1222, 278, 1183, 278], "text": "for"}, {"boundingBox": [1228, 241, 1434, 239, 1435, 276, 1229, 278], "text": "individualized"}]}, {"boundingBox": [307, 280, 419, 284, 418, 317, 305, 313], "text": "therapy", "words": [{"boundingBox": [307, 281, 417, 284, 417, 317, 307, 314], "text": "therapy"}]}, {"boundingBox": [205, 392, 611, 395, 610, 434, 204, 431], "text": "8.3 Optimal Positioning", "words": [{"boundingBox": [207, 395, 259, 394, 259, 431, 208, 431], "text": "8.3"}, {"boundingBox": [287, 394, 414, 394, 413, 433, 287, 432], "text": "Optimal"}, {"boundingBox": [421, 394, 608, 397, 608, 434, 421, 433], "text": "Positioning"}]}, {"boundingBox": [206, 472, 1498, 473, 1498, 508, 205, 507], "text": "The goal of positioning Premarin /TMG is to compliment the current Wyeth HT portfolio.", "words": [{"boundingBox": [209, 473, 264, 474, 265, 508, 209, 509], "text": "The"}, {"boundingBox": [271, 474, 338, 474, 339, 508, 272, 508], "text": "goal"}, {"boundingBox": [345, 474, 373, 474, 374, 508, 346, 508], "text": "of"}, {"boundingBox": [380, 474, 542, 475, 543, 508, 381, 508], "text": "positioning"}, {"boundingBox": [549, 475, 686, 475, 686, 508, 550, 508], "text": "Premarin"}, {"boundingBox": [693, 475, 779, 475, 779, 508, 693, 508], "text": "/TMG"}, {"boundingBox": [785, 475, 813, 475, 814, 508, 786, 508], "text": "is"}, {"boundingBox": [820, 475, 850, 475, 851, 508, 821, 508], "text": "to"}, {"boundingBox": [857, 475, 1031, 475, 1031, 508, 858, 508], "text": "compliment"}, {"boundingBox": [1038, 475, 1087, 475, 1087, 508, 1038, 508], "text": "the"}, {"boundingBox": [1094, 475, 1200, 474, 1201, 508, 1094, 508], "text": "current"}, {"boundingBox": [1207, 474, 1305, 474, 1305, 508, 1207, 508], "text": "Wyeth"}, {"boundingBox": [1311, 474, 1358, 474, 1358, 509, 1312, 508], "text": "HT"}, {"boundingBox": [1365, 474, 1497, 473, 1497, 509, 1365, 509], "text": "portfolio."}]}, {"boundingBox": [206, 509, 1458, 512, 1457, 549, 205, 546], "text": "The focus will be to position Premarin/TMG in a manner that minimizes cannibalizing", "words": [{"boundingBox": [210, 510, 265, 510, 263, 547, 209, 547], "text": "The"}, {"boundingBox": [272, 510, 353, 510, 352, 547, 270, 547], "text": "focus"}, {"boundingBox": [361, 510, 410, 510, 409, 547, 359, 547], "text": "will"}, {"boundingBox": [417, 510, 457, 510, 455, 547, 416, 547], "text": "be"}, {"boundingBox": [464, 510, 494, 511, 492, 547, 463, 547], "text": "to"}, {"boundingBox": [501, 511, 620, 511, 618, 547, 500, 547], "text": "position"}, {"boundingBox": [627, 511, 844, 512, 843, 548, 626, 547], "text": "Premarin/TMG"}, {"boundingBox": [851, 512, 883, 512, 882, 548, 850, 548], "text": "in"}, {"boundingBox": [891, 512, 908, 512, 907, 548, 890, 548], "text": "a"}, {"boundingBox": [915, 512, 1031, 512, 1030, 548, 914, 548], "text": "manner"}, {"boundingBox": [1039, 512, 1095, 512, 1094, 548, 1038, 548], "text": "that"}, {"boundingBox": [1103, 512, 1258, 513, 1257, 549, 1102, 548], "text": "minimizes"}, {"boundingBox": [1266, 513, 1458, 513, 1457, 549, 1264, 549], "text": "cannibalizing"}]}, {"boundingBox": [206, 550, 1410, 549, 1411, 585, 207, 586], "text": "our own products and captures valuable market share that has been lost to NETA", "words": [{"boundingBox": [207, 552, 257, 552, 258, 585, 208, 585], "text": "our"}, {"boundingBox": [263, 552, 326, 551, 327, 585, 264, 585], "text": "own"}, {"boundingBox": [333, 551, 465, 551, 465, 586, 333, 585], "text": "products"}, {"boundingBox": [471, 551, 530, 551, 530, 586, 472, 586], "text": "and"}, {"boundingBox": [536, 551, 666, 551, 667, 586, 537, 586], "text": "captures"}, {"boundingBox": [673, 551, 799, 550, 799, 586, 673, 586], "text": "valuable"}, {"boundingBox": [805, 550, 911, 550, 911, 586, 805, 586], "text": "market"}, {"boundingBox": [918, 550, 1004, 550, 1005, 586, 918, 586], "text": "share"}, {"boundingBox": [1011, 550, 1067, 550, 1067, 586, 1011, 586], "text": "that"}, {"boundingBox": [1074, 550, 1132, 550, 1132, 586, 1074, 586], "text": "has"}, {"boundingBox": [1139, 550, 1215, 550, 1215, 586, 1139, 586], "text": "been"}, {"boundingBox": [1221, 550, 1277, 550, 1277, 585, 1221, 586], "text": "lost"}, {"boundingBox": [1284, 550, 1314, 550, 1314, 585, 1284, 585], "text": "to"}, {"boundingBox": [1321, 550, 1410, 550, 1409, 585, 1321, 585], "text": "NETA"}]}, {"boundingBox": [198, 587, 1459, 588, 1458, 624, 197, 623], "text": "based products. Based on the results of the clinical trial and physician reaction to the", "words": [{"boundingBox": [203, 588, 298, 588, 299, 622, 205, 622], "text": "based"}, {"boundingBox": [304, 588, 446, 589, 447, 623, 306, 623], "text": "products."}, {"boundingBox": [452, 589, 549, 589, 550, 624, 454, 623], "text": "Based"}, {"boundingBox": [556, 589, 596, 589, 597, 624, 557, 624], "text": "on"}, {"boundingBox": [602, 589, 651, 589, 652, 624, 603, 624], "text": "the"}, {"boundingBox": [657, 589, 759, 589, 760, 624, 658, 624], "text": "results"}, {"boundingBox": [765, 589, 796, 589, 797, 624, 766, 624], "text": "of"}, {"boundingBox": [803, 589, 851, 589, 852, 624, 804, 624], "text": "the"}, {"boundingBox": [858, 589, 960, 589, 960, 624, 859, 624], "text": "clinical"}, {"boundingBox": [966, 589, 1023, 589, 1024, 624, 967, 624], "text": "trial"}, {"boundingBox": [1030, 589, 1087, 589, 1088, 624, 1031, 624], "text": "and"}, {"boundingBox": [1094, 589, 1237, 588, 1238, 624, 1095, 624], "text": "physician"}, {"boundingBox": [1244, 588, 1368, 588, 1368, 623, 1245, 624], "text": "reaction"}, {"boundingBox": [1374, 588, 1403, 588, 1403, 623, 1375, 623], "text": "to"}, {"boundingBox": [1410, 588, 1458, 588, 1458, 623, 1410, 623], "text": "the"}]}, {"boundingBox": [203, 623, 1045, 626, 1044, 664, 203, 662], "text": "Premarin/TMG product profile, the working positioning is:", "words": [{"boundingBox": [206, 625, 426, 625, 426, 662, 206, 662], "text": "Premarin/TMG"}, {"boundingBox": [433, 625, 547, 625, 546, 663, 433, 662], "text": "product"}, {"boundingBox": [554, 625, 656, 626, 655, 663, 554, 663], "text": "profile,"}, {"boundingBox": [663, 626, 711, 626, 711, 663, 662, 663], "text": "the"}, {"boundingBox": [718, 626, 834, 627, 834, 664, 718, 663], "text": "working"}, {"boundingBox": [842, 627, 1004, 628, 1003, 665, 841, 664], "text": "positioning"}, {"boundingBox": [1011, 628, 1045, 628, 1044, 665, 1010, 665], "text": "is:"}]}, {"boundingBox": [476, 702, 1240, 705, 1239, 740, 475, 738], "text": "The trusted estrogen combined with a low dose,", "words": [{"boundingBox": [479, 703, 537, 704, 537, 737, 478, 736], "text": "The"}, {"boundingBox": [544, 704, 661, 705, 661, 739, 544, 737], "text": "trusted"}, {"boundingBox": [667, 705, 808, 706, 809, 740, 667, 739], "text": "estrogen"}, {"boundingBox": [817, 706, 975, 707, 976, 740, 817, 740], "text": "combined"}, {"boundingBox": [982, 707, 1049, 706, 1050, 740, 982, 740], "text": "with"}, {"boundingBox": [1058, 706, 1077, 706, 1078, 739, 1058, 740], "text": "a"}, {"boundingBox": [1084, 706, 1136, 706, 1137, 739, 1085, 739], "text": "low"}, {"boundingBox": [1160, 706, 1238, 705, 1239, 738, 1161, 739], "text": "dose,"}]}, {"boundingBox": [414, 739, 1300, 741, 1299, 778, 414, 777], "text": "highly selective progestin offering menopausal women", "words": [{"boundingBox": [421, 741, 522, 741, 521, 778, 419, 777], "text": "highly"}, {"boundingBox": [529, 741, 669, 742, 668, 778, 528, 778], "text": "selective"}, {"boundingBox": [677, 742, 834, 743, 833, 778, 676, 778], "text": "progestin"}, {"boundingBox": [841, 743, 964, 744, 964, 777, 840, 778], "text": "offering"}, {"boundingBox": [971, 744, 1170, 745, 1170, 777, 971, 777], "text": "menopausal"}, {"boundingBox": [1177, 745, 1298, 745, 1298, 776, 1177, 777], "text": "women"}]}, {"boundingBox": [513, 781, 1195, 780, 1195, 817, 514, 818], "text": "symptom relief and improved quality of life", "words": [{"boundingBox": [517, 783, 657, 782, 656, 818, 517, 816], "text": "symptom"}, {"boundingBox": [672, 782, 757, 782, 756, 818, 671, 818], "text": "relief"}, {"boundingBox": [764, 782, 825, 781, 824, 819, 763, 818], "text": "and"}, {"boundingBox": [831, 781, 984, 781, 983, 819, 830, 819], "text": "improved"}, {"boundingBox": [990, 781, 1102, 781, 1101, 819, 989, 819], "text": "quality"}, {"boundingBox": [1108, 781, 1141, 781, 1140, 818, 1107, 819], "text": "of"}, {"boundingBox": [1147, 781, 1193, 781, 1192, 818, 1146, 818], "text": "life"}]}, {"boundingBox": [204, 857, 1457, 856, 1457, 892, 205, 893], "text": "The positioning of Premarin/TMG will be dependant on the market acceptance of the", "words": [{"boundingBox": [207, 857, 265, 857, 265, 893, 208, 893], "text": "The"}, {"boundingBox": [272, 857, 436, 858, 436, 894, 272, 893], "text": "positioning"}, {"boundingBox": [443, 858, 471, 858, 471, 894, 443, 894], "text": "of"}, {"boundingBox": [478, 858, 699, 858, 699, 894, 478, 894], "text": "Premarin/TMG"}, {"boundingBox": [707, 858, 754, 858, 754, 894, 706, 894], "text": "will"}, {"boundingBox": [761, 858, 804, 858, 803, 894, 761, 894], "text": "be"}, {"boundingBox": [813, 858, 968, 858, 967, 894, 813, 894], "text": "dependant"}, {"boundingBox": [975, 858, 1015, 858, 1015, 894, 974, 894], "text": "on"}, {"boundingBox": [1023, 858, 1070, 858, 1069, 894, 1022, 894], "text": "the"}, {"boundingBox": [1077, 858, 1184, 858, 1183, 893, 1076, 894], "text": "market"}, {"boundingBox": [1191, 858, 1365, 858, 1364, 893, 1190, 893], "text": "acceptance"}, {"boundingBox": [1372, 858, 1400, 858, 1399, 893, 1371, 893], "text": "of"}, {"boundingBox": [1408, 858, 1458, 858, 1456, 893, 1406, 893], "text": "the"}]}, {"boundingBox": [205, 894, 1447, 895, 1446, 933, 204, 932], "text": "lower doses of Prempro in the US and the evolving market dynamics. Therefore, the", "words": [{"boundingBox": [205, 895, 293, 895, 292, 932, 205, 932], "text": "lower"}, {"boundingBox": [300, 895, 386, 895, 385, 932, 300, 932], "text": "doses"}, {"boundingBox": [393, 895, 422, 895, 421, 932, 392, 932], "text": "of"}, {"boundingBox": [430, 895, 559, 896, 558, 932, 429, 932], "text": "Prempro"}, {"boundingBox": [566, 896, 595, 896, 594, 932, 565, 932], "text": "in"}, {"boundingBox": [603, 896, 651, 896, 650, 932, 602, 932], "text": "the"}, {"boundingBox": [659, 896, 708, 896, 707, 932, 658, 932], "text": "US"}, {"boundingBox": [715, 896, 771, 896, 770, 932, 714, 932], "text": "and"}, {"boundingBox": [778, 896, 827, 896, 826, 932, 777, 932], "text": "the"}, {"boundingBox": [834, 896, 956, 896, 955, 932, 833, 932], "text": "evolving"}, {"boundingBox": [963, 896, 1073, 896, 1072, 933, 962, 932], "text": "market"}, {"boundingBox": [1080, 896, 1234, 896, 1233, 933, 1079, 933], "text": "dynamics."}, {"boundingBox": [1241, 896, 1393, 896, 1391, 933, 1240, 933], "text": "Therefore,"}, {"boundingBox": [1400, 896, 1446, 896, 1445, 933, 1398, 933], "text": "the"}]}, {"boundingBox": [207, 933, 1245, 934, 1244, 971, 206, 971], "text": "positioning of Premarin/TMG will continue to be assessed and refined.", "words": [{"boundingBox": [207, 936, 368, 935, 369, 971, 208, 972], "text": "positioning"}, {"boundingBox": [375, 935, 403, 935, 404, 971, 376, 971], "text": "of"}, {"boundingBox": [410, 935, 630, 934, 631, 970, 411, 971], "text": "Premarin/TMG"}, {"boundingBox": [640, 934, 689, 934, 690, 970, 641, 970], "text": "will"}, {"boundingBox": [696, 935, 822, 935, 823, 970, 697, 970], "text": "continue"}, {"boundingBox": [829, 935, 859, 935, 861, 970, 830, 970], "text": "to"}, {"boundingBox": [866, 935, 906, 935, 908, 970, 868, 970], "text": "be"}, {"boundingBox": [913, 935, 1058, 936, 1060, 970, 915, 970], "text": "assessed"}, {"boundingBox": [1065, 936, 1121, 937, 1123, 970, 1067, 970], "text": "and"}, {"boundingBox": [1128, 937, 1243, 938, 1245, 970, 1130, 970], "text": "refined."}]}, {"boundingBox": [201, 1047, 1405, 1049, 1404, 1086, 200, 1085], "text": "However, it is clear, Premarin/TMG is an important new HT option for physicians.", "words": [{"boundingBox": [206, 1048, 348, 1049, 346, 1086, 203, 1085], "text": "However,"}, {"boundingBox": [355, 1049, 374, 1049, 372, 1086, 353, 1086], "text": "it"}, {"boundingBox": [382, 1049, 409, 1050, 407, 1086, 380, 1086], "text": "is"}, {"boundingBox": [416, 1050, 499, 1050, 497, 1086, 414, 1086], "text": "clear,"}, {"boundingBox": [506, 1050, 726, 1051, 725, 1086, 505, 1086], "text": "Premarin/TMG"}, {"boundingBox": [733, 1051, 763, 1051, 762, 1086, 732, 1086], "text": "is"}, {"boundingBox": [770, 1051, 807, 1051, 806, 1086, 769, 1086], "text": "an"}, {"boundingBox": [814, 1051, 956, 1051, 955, 1086, 813, 1086], "text": "important"}, {"boundingBox": [963, 1051, 1024, 1051, 1024, 1086, 963, 1086], "text": "new"}, {"boundingBox": [1031, 1051, 1080, 1051, 1080, 1086, 1031, 1086], "text": "HT"}, {"boundingBox": [1087, 1051, 1180, 1050, 1181, 1086, 1088, 1086], "text": "option"}, {"boundingBox": [1187, 1050, 1229, 1050, 1230, 1086, 1188, 1086], "text": "for"}, {"boundingBox": [1236, 1050, 1405, 1049, 1406, 1086, 1237, 1086], "text": "physicians."}]}, {"boundingBox": [205, 1087, 1294, 1089, 1293, 1125, 204, 1123], "text": "Physicians want new progestin choices and patient management options.", "words": [{"boundingBox": [206, 1088, 366, 1090, 366, 1123, 205, 1123], "text": "Physicians"}, {"boundingBox": [372, 1090, 447, 1091, 447, 1124, 372, 1123], "text": "want"}, {"boundingBox": [454, 1091, 512, 1091, 513, 1124, 454, 1124], "text": "new"}, {"boundingBox": [524, 1091, 666, 1092, 666, 1124, 524, 1124], "text": "progestin"}, {"boundingBox": [672, 1092, 788, 1092, 789, 1124, 673, 1124], "text": "choices"}, {"boundingBox": [794, 1092, 851, 1092, 852, 1124, 795, 1124], "text": "and"}, {"boundingBox": [857, 1092, 959, 1092, 960, 1124, 859, 1124], "text": "patient"}, {"boundingBox": [966, 1092, 1167, 1092, 1169, 1124, 967, 1124], "text": "management"}, {"boundingBox": [1173, 1092, 1291, 1091, 1293, 1123, 1175, 1124], "text": "options."}]}, {"boundingBox": [207, 1124, 1372, 1126, 1371, 1164, 206, 1162], "text": "Premarin/TMG provides this option while allowing prescribers to stay within the", "words": [{"boundingBox": [209, 1125, 425, 1126, 424, 1163, 207, 1162], "text": "Premarin/TMG"}, {"boundingBox": [432, 1126, 561, 1126, 561, 1163, 431, 1163], "text": "provides"}, {"boundingBox": [569, 1126, 622, 1126, 622, 1163, 568, 1163], "text": "this"}, {"boundingBox": [629, 1126, 722, 1126, 722, 1163, 629, 1163], "text": "option"}, {"boundingBox": [729, 1126, 807, 1126, 807, 1163, 729, 1163], "text": "while"}, {"boundingBox": [814, 1126, 936, 1127, 936, 1164, 814, 1163], "text": "allowing"}, {"boundingBox": [943, 1127, 1111, 1127, 1112, 1164, 944, 1164], "text": "prescribers"}, {"boundingBox": [1118, 1127, 1150, 1127, 1151, 1164, 1119, 1164], "text": "to"}, {"boundingBox": [1157, 1127, 1218, 1127, 1219, 1164, 1158, 1164], "text": "stay"}, {"boundingBox": [1225, 1127, 1313, 1127, 1314, 1164, 1226, 1164], "text": "within"}, {"boundingBox": [1320, 1127, 1369, 1127, 1370, 1164, 1322, 1164], "text": "the"}]}, {"boundingBox": [207, 1164, 1413, 1163, 1414, 1201, 208, 1202], "text": "Premarin Family of products. Premarin/TMG further reinforces Wyeth's leadership", "words": [{"boundingBox": [208, 1165, 343, 1165, 343, 1202, 208, 1202], "text": "Premarin"}, {"boundingBox": [350, 1165, 449, 1165, 449, 1203, 350, 1202], "text": "Family"}, {"boundingBox": [457, 1165, 486, 1165, 485, 1203, 456, 1203], "text": "of"}, {"boundingBox": [493, 1165, 633, 1164, 633, 1203, 493, 1203], "text": "products."}, {"boundingBox": [640, 1164, 860, 1164, 860, 1203, 640, 1203], "text": "Premarin/TMG"}, {"boundingBox": [867, 1164, 966, 1165, 966, 1202, 867, 1203], "text": "further"}, {"boundingBox": [973, 1165, 1121, 1165, 1121, 1201, 973, 1202], "text": "reinforces"}, {"boundingBox": [1128, 1165, 1251, 1165, 1251, 1201, 1128, 1201], "text": "Wyeth's"}, {"boundingBox": [1258, 1165, 1413, 1166, 1413, 1199, 1258, 1201], "text": "leadership"}]}, {"boundingBox": [207, 1206, 1403, 1205, 1404, 1238, 207, 1239], "text": "position through continued innovation to address the range of needs among both", "words": [{"boundingBox": [207, 1206, 321, 1206, 323, 1239, 209, 1239], "text": "position"}, {"boundingBox": [328, 1206, 444, 1206, 446, 1240, 330, 1239], "text": "through"}, {"boundingBox": [451, 1206, 598, 1207, 600, 1240, 453, 1240], "text": "continued"}, {"boundingBox": [605, 1207, 759, 1207, 761, 1240, 607, 1240], "text": "innovation"}, {"boundingBox": [765, 1207, 798, 1207, 800, 1239, 767, 1240], "text": "to"}, {"boundingBox": [805, 1207, 923, 1206, 926, 1239, 807, 1239], "text": "address"}, {"boundingBox": [930, 1206, 978, 1206, 981, 1239, 932, 1239], "text": "the"}, {"boundingBox": [985, 1206, 1075, 1206, 1077, 1239, 987, 1239], "text": "range"}, {"boundingBox": [1082, 1206, 1110, 1206, 1112, 1239, 1084, 1239], "text": "of"}, {"boundingBox": [1117, 1206, 1214, 1206, 1216, 1239, 1119, 1239], "text": "needs"}, {"boundingBox": [1220, 1206, 1323, 1206, 1326, 1239, 1222, 1239], "text": "among"}, {"boundingBox": [1330, 1206, 1398, 1206, 1401, 1239, 1332, 1239], "text": "both"}]}, {"boundingBox": [205, 1242, 625, 1241, 626, 1278, 206, 1279], "text": "women and their physicians.", "words": [{"boundingBox": [206, 1245, 316, 1243, 315, 1278, 206, 1280], "text": "women"}, {"boundingBox": [322, 1243, 382, 1242, 381, 1277, 322, 1278], "text": "and"}, {"boundingBox": [389, 1242, 455, 1243, 454, 1277, 388, 1277], "text": "their"}, {"boundingBox": [462, 1243, 626, 1246, 625, 1278, 461, 1277], "text": "physicians."}]}, {"boundingBox": [203, 1317, 1370, 1318, 1369, 1354, 202, 1353], "text": "Given the importance of differentiating based on the progestin, building market", "words": [{"boundingBox": [208, 1318, 295, 1319, 294, 1353, 208, 1352], "text": "Given"}, {"boundingBox": [301, 1319, 350, 1319, 350, 1353, 301, 1353], "text": "the"}, {"boundingBox": [357, 1319, 526, 1319, 526, 1354, 357, 1353], "text": "importance"}, {"boundingBox": [533, 1320, 566, 1320, 566, 1354, 533, 1354], "text": "of"}, {"boundingBox": [573, 1320, 771, 1320, 771, 1354, 573, 1354], "text": "differentiating"}, {"boundingBox": [777, 1320, 873, 1320, 873, 1354, 778, 1354], "text": "based"}, {"boundingBox": [880, 1320, 917, 1320, 918, 1354, 880, 1354], "text": "on"}, {"boundingBox": [924, 1320, 973, 1319, 974, 1354, 925, 1354], "text": "the"}, {"boundingBox": [980, 1319, 1129, 1319, 1129, 1354, 980, 1354], "text": "progestin,"}, {"boundingBox": [1135, 1319, 1255, 1318, 1256, 1353, 1136, 1354], "text": "building"}, {"boundingBox": [1262, 1318, 1369, 1318, 1370, 1353, 1263, 1353], "text": "market"}]}, {"boundingBox": [198, 1357, 1480, 1355, 1481, 1392, 199, 1393], "text": "awareness of trimegestone is important. Therefore, the message platform for TMG will", "words": [{"boundingBox": [207, 1359, 370, 1359, 369, 1393, 205, 1393], "text": "awareness"}, {"boundingBox": [377, 1359, 407, 1359, 406, 1393, 375, 1393], "text": "of"}, {"boundingBox": [414, 1359, 608, 1359, 607, 1393, 413, 1393], "text": "trimegestone"}, {"boundingBox": [614, 1359, 640, 1359, 640, 1393, 613, 1393], "text": "is"}, {"boundingBox": [647, 1359, 804, 1359, 803, 1393, 646, 1393], "text": "important."}, {"boundingBox": [810, 1359, 963, 1358, 963, 1393, 810, 1393], "text": "Therefore,"}, {"boundingBox": [969, 1358, 1017, 1358, 1017, 1393, 969, 1393], "text": "the"}, {"boundingBox": [1024, 1358, 1163, 1358, 1163, 1393, 1024, 1393], "text": "message"}, {"boundingBox": [1170, 1358, 1285, 1357, 1286, 1393, 1170, 1393], "text": "platform"}, {"boundingBox": [1300, 1357, 1344, 1357, 1345, 1393, 1301, 1393], "text": "for"}, {"boundingBox": [1350, 1357, 1420, 1357, 1421, 1393, 1351, 1393], "text": "TMG"}, {"boundingBox": [1431, 1357, 1479, 1356, 1480, 1392, 1432, 1392], "text": "will"}]}, {"boundingBox": [199, 1394, 1479, 1395, 1478, 1433, 198, 1432], "text": "be established pre-launch. Based on careful scrutiny of the available clinical data(both", "words": [{"boundingBox": [204, 1395, 247, 1395, 245, 1432, 202, 1431], "text": "be"}, {"boundingBox": [254, 1395, 423, 1396, 421, 1432, 252, 1432], "text": "established"}, {"boundingBox": [430, 1396, 599, 1397, 598, 1433, 428, 1432], "text": "pre-launch."}, {"boundingBox": [607, 1397, 704, 1397, 703, 1433, 605, 1433], "text": "Based"}, {"boundingBox": [711, 1397, 750, 1397, 748, 1433, 710, 1433], "text": "on"}, {"boundingBox": [757, 1397, 859, 1397, 858, 1433, 756, 1433], "text": "careful"}, {"boundingBox": [866, 1397, 983, 1397, 983, 1434, 865, 1434], "text": "scrutiny"}, {"boundingBox": [990, 1397, 1019, 1397, 1018, 1434, 990, 1434], "text": "of"}, {"boundingBox": [1026, 1397, 1076, 1397, 1076, 1434, 1025, 1434], "text": "the"}, {"boundingBox": [1083, 1397, 1219, 1397, 1219, 1434, 1083, 1434], "text": "available"}, {"boundingBox": [1226, 1396, 1333, 1396, 1334, 1434, 1226, 1434], "text": "clinical"}, {"boundingBox": [1341, 1396, 1479, 1395, 1479, 1434, 1341, 1434], "text": "data(both"}]}, {"boundingBox": [203, 1433, 1319, 1435, 1318, 1473, 202, 1472], "text": "Premarin/TMG and Totelle), the \"Essence of TMG \" has been described as:", "words": [{"boundingBox": [206, 1435, 425, 1435, 424, 1472, 205, 1471], "text": "Premarin/TMG"}, {"boundingBox": [434, 1435, 495, 1435, 494, 1473, 434, 1472], "text": "and"}, {"boundingBox": [502, 1435, 620, 1435, 620, 1473, 501, 1473], "text": "Totelle),"}, {"boundingBox": [627, 1435, 674, 1435, 674, 1473, 627, 1473], "text": "the"}, {"boundingBox": [681, 1435, 825, 1435, 825, 1473, 681, 1473], "text": "\"Essence"}, {"boundingBox": [832, 1435, 865, 1435, 865, 1473, 832, 1473], "text": "of"}, {"boundingBox": [872, 1435, 941, 1436, 942, 1473, 872, 1473], "text": "TMG"}, {"boundingBox": [948, 1436, 965, 1436, 965, 1473, 949, 1473], "text": "\""}, {"boundingBox": [972, 1436, 1027, 1436, 1028, 1472, 972, 1473], "text": "has"}, {"boundingBox": [1034, 1436, 1113, 1437, 1115, 1472, 1035, 1472], "text": "been"}, {"boundingBox": [1123, 1437, 1267, 1438, 1269, 1471, 1124, 1472], "text": "described"}, {"boundingBox": [1274, 1438, 1316, 1438, 1318, 1470, 1276, 1471], "text": "as:"}]}, {"boundingBox": [206, 1509, 807, 1512, 806, 1551, 206, 1549], "text": "1. A highly selective low dose progestin", "words": [{"boundingBox": [209, 1510, 248, 1511, 245, 1550, 206, 1550], "text": "1."}, {"boundingBox": [256, 1511, 279, 1511, 276, 1549, 253, 1550], "text": "A"}, {"boundingBox": [287, 1511, 378, 1512, 375, 1549, 284, 1549], "text": "highly"}, {"boundingBox": [386, 1512, 515, 1513, 513, 1549, 383, 1549], "text": "selective"}, {"boundingBox": [523, 1513, 575, 1513, 573, 1549, 521, 1549], "text": "low"}, {"boundingBox": [591, 1513, 656, 1514, 654, 1549, 589, 1549], "text": "dose"}, {"boundingBox": [663, 1514, 806, 1515, 805, 1550, 662, 1549], "text": "progestin"}]}, {"boundingBox": [205, 1549, 664, 1551, 663, 1590, 205, 1589], "text": "2. Progesterone-like progestin", "words": [{"boundingBox": [207, 1550, 247, 1550, 245, 1589, 205, 1590], "text": "2."}, {"boundingBox": [255, 1550, 517, 1552, 516, 1586, 253, 1589], "text": "Progesterone-like"}, {"boundingBox": [525, 1552, 663, 1554, 663, 1589, 524, 1586], "text": "progestin"}]}, {"boundingBox": [214, 1590, 1284, 1588, 1285, 1624, 215, 1625], "text": ". Providing effective endometrial protection and a good bleeding profile", "words": [{"boundingBox": [224, 1590, 248, 1590, 246, 1626, 222, 1626], "text": "."}, {"boundingBox": [255, 1590, 398, 1590, 396, 1625, 253, 1626], "text": "Providing"}, {"boundingBox": [405, 1590, 531, 1590, 530, 1625, 403, 1625], "text": "effective"}, {"boundingBox": [538, 1590, 712, 1590, 711, 1625, 537, 1625], "text": "endometrial"}, {"boundingBox": [719, 1590, 871, 1590, 871, 1624, 718, 1625], "text": "protection"}, {"boundingBox": [878, 1590, 935, 1590, 935, 1624, 878, 1624], "text": "and"}, {"boundingBox": [942, 1590, 961, 1590, 962, 1624, 943, 1624], "text": "a"}, {"boundingBox": [968, 1590, 1044, 1590, 1045, 1624, 969, 1624], "text": "good"}, {"boundingBox": [1052, 1590, 1180, 1590, 1181, 1624, 1052, 1624], "text": "bleeding"}, {"boundingBox": [1187, 1590, 1282, 1590, 1284, 1624, 1188, 1624], "text": "profile"}]}, {"boundingBox": [206, 1624, 1381, 1626, 1380, 1665, 205, 1664], "text": "4. Having minimal impact on other body system receptors: GABA, androgenic,", "words": [{"boundingBox": [208, 1626, 247, 1627, 245, 1664, 206, 1663], "text": "4."}, {"boundingBox": [254, 1627, 361, 1627, 360, 1664, 253, 1664], "text": "Having"}, {"boundingBox": [368, 1627, 483, 1627, 482, 1664, 367, 1664], "text": "minimal"}, {"boundingBox": [490, 1627, 595, 1628, 594, 1665, 489, 1664], "text": "impact"}, {"boundingBox": [602, 1628, 641, 1628, 640, 1665, 601, 1665], "text": "on"}, {"boundingBox": [648, 1628, 724, 1628, 723, 1665, 648, 1665], "text": "other"}, {"boundingBox": [731, 1628, 806, 1628, 806, 1665, 731, 1665], "text": "body"}, {"boundingBox": [814, 1628, 916, 1628, 916, 1665, 814, 1665], "text": "system"}, {"boundingBox": [928, 1628, 1081, 1627, 1082, 1666, 928, 1665], "text": "receptors:"}, {"boundingBox": [1089, 1627, 1193, 1627, 1194, 1666, 1089, 1666], "text": "GABA,"}, {"boundingBox": [1201, 1627, 1381, 1626, 1382, 1666, 1201, 1666], "text": "androgenic,"}]}, {"boundingBox": [256, 1666, 655, 1667, 654, 1701, 255, 1700], "text": "mineralocorticoid, estrogen", "words": [{"boundingBox": [256, 1670, 520, 1667, 521, 1702, 256, 1700], "text": "mineralocorticoid,"}, {"boundingBox": [526, 1667, 653, 1670, 654, 1701, 527, 1702], "text": "estrogen"}]}, {"boundingBox": [208, 1703, 745, 1704, 744, 1740, 207, 1739], "text": "5. Non-androgenic/less weight gain", "words": [{"boundingBox": [208, 1705, 245, 1705, 246, 1740, 209, 1740], "text": "5."}, {"boundingBox": [252, 1705, 563, 1706, 564, 1740, 253, 1740], "text": "Non-androgenic/less"}, {"boundingBox": [569, 1706, 669, 1705, 671, 1740, 571, 1740], "text": "weight"}, {"boundingBox": [676, 1705, 741, 1704, 743, 1740, 678, 1740], "text": "gain"}]}, {"boundingBox": [205, 1741, 681, 1743, 680, 1779, 204, 1777], "text": "6. No negative impact on mood", "words": [{"boundingBox": [205, 1743, 247, 1742, 248, 1778, 206, 1778], "text": "6."}, {"boundingBox": [254, 1742, 298, 1742, 299, 1778, 255, 1778], "text": "No"}, {"boundingBox": [305, 1742, 435, 1743, 435, 1779, 306, 1778], "text": "negative"}, {"boundingBox": [442, 1743, 546, 1744, 547, 1779, 442, 1779], "text": "impact"}, {"boundingBox": [553, 1744, 591, 1745, 591, 1778, 553, 1779], "text": "on"}, {"boundingBox": [598, 1745, 681, 1746, 681, 1778, 598, 1778], "text": "mood"}]}, {"boundingBox": [200, 1777, 491, 1778, 490, 1818, 200, 1818], "text": "7. Improved QuoL", "words": [{"boundingBox": [206, 1779, 245, 1779, 245, 1818, 205, 1818], "text": "7."}, {"boundingBox": [253, 1779, 397, 1781, 397, 1816, 253, 1817], "text": "Improved"}, {"boundingBox": [405, 1781, 489, 1781, 489, 1817, 405, 1816], "text": "QuoL"}]}, {"boundingBox": [199, 1855, 1395, 1853, 1396, 1895, 200, 1897], "text": "Key pre-launch activities will focus on creating the \"essences\" of profile for TMG.", "words": [{"boundingBox": [205, 1857, 263, 1857, 264, 1896, 206, 1895], "text": "Key"}, {"boundingBox": [270, 1857, 432, 1858, 433, 1896, 271, 1896], "text": "pre-launch"}, {"boundingBox": [440, 1858, 568, 1858, 569, 1897, 441, 1896], "text": "activities"}, {"boundingBox": [576, 1858, 624, 1858, 625, 1897, 577, 1897], "text": "will"}, {"boundingBox": [631, 1858, 715, 1858, 716, 1897, 632, 1897], "text": "focus"}, {"boundingBox": [722, 1858, 760, 1858, 761, 1897, 723, 1897], "text": "on"}, {"boundingBox": [768, 1858, 886, 1857, 888, 1897, 769, 1897], "text": "creating"}, {"boundingBox": [894, 1857, 942, 1857, 943, 1897, 895, 1897], "text": "the"}, {"boundingBox": [949, 1857, 1116, 1856, 1117, 1896, 951, 1897], "text": "\"essences\""}, {"boundingBox": [1123, 1856, 1151, 1856, 1153, 1896, 1125, 1896], "text": "of"}, {"boundingBox": [1159, 1856, 1252, 1855, 1254, 1896, 1160, 1896], "text": "profile"}, {"boundingBox": [1260, 1855, 1305, 1855, 1307, 1896, 1261, 1896], "text": "for"}, {"boundingBox": [1313, 1855, 1393, 1854, 1395, 1895, 1314, 1895], "text": "TMG."}]}, {"boundingBox": [198, 2071, 407, 2069, 407, 2106, 199, 2109], "text": "Confidential", "words": [{"boundingBox": [206, 2072, 407, 2069, 406, 2107, 208, 2108], "text": "Confidential"}]}, {"boundingBox": [803, 2070, 933, 2071, 932, 2106, 802, 2105], "text": "27 of 42", "words": [{"boundingBox": [808, 2071, 845, 2071, 844, 2106, 807, 2105], "text": "27"}, {"boundingBox": [852, 2071, 893, 2071, 892, 2106, 851, 2106], "text": "of"}, {"boundingBox": [899, 2071, 931, 2071, 931, 2107, 899, 2106], "text": "42"}]}, {"boundingBox": [21, 2198, 492, 2204, 491, 2235, 20, 2229], "text": "Confidential Pursuant to Confidentiality", "words": [{"boundingBox": [22, 2199, 166, 2201, 167, 2231, 21, 2229], "text": "Confidential"}, {"boundingBox": [172, 2201, 282, 2202, 283, 2233, 172, 2231], "text": "Pursuant"}, {"boundingBox": [288, 2202, 315, 2203, 316, 2233, 289, 2233], "text": "to"}, {"boundingBox": [321, 2203, 491, 2205, 492, 2234, 321, 2233], "text": "Confidentiality"}]}, {"boundingBox": [1430, 2208, 1676, 2208, 1675, 2236, 1429, 2235], "text": "KERZC001-000300", "words": [{"boundingBox": [1436, 2208, 1676, 2210, 1676, 2236, 1436, 2236], "text": "KERZC001-000300"}]}, {"boundingBox": [27, 2234, 99, 2235, 98, 2261, 26, 2260], "text": "Order", "words": [{"boundingBox": [27, 2235, 98, 2235, 99, 2260, 27, 2259], "text": "Order"}]}, {"boundingBox": [372, 2243, 1331, 2242, 1331, 2280, 373, 2282], "text": "Source: https://www.industrydocuments.ucsf.edu/docs/yrvw0217", "words": [{"boundingBox": [379, 2247, 494, 2246, 494, 2280, 380, 2279], "text": "Source:"}, {"boundingBox": [500, 2246, 1330, 2242, 1330, 2279, 501, 2280], "text": "https://www.industrydocuments.ucsf.edu/docs/yrvw0217"}]}]}]}